Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients

Medicine & Life Sciences

• Amphotericin B 21%
• Antacids 8%
• Aspergillus 14%
• Biological Availability 5%
• Candida 6%
• Candida albicans 6%
• Candida glabrata 8%
• Costs and Cost Analysis 3%
• Diarrhea 5%
• Drug-Related Side Effects and Adverse Reactions 5%
• Fluconazole 95%
• Histamine H2 Receptors 8%
• Incidence 3%
• Infections 3%
• Invasive Fungal Infections 8%
• Itraconazole 100%
• Lipids 4%
• Liver Transplantation 75%
• Mortality 3%
• Mycoses 84%
• Nausea 5%
• Pharmaceutical Preparations 2%
• Randomized Controlled Trials 56%
• Safety 7%
• Transplant Recipients 77%
• Transplantation 9%
• Transplants 4%
• Vomiting 5%